Maple Grove med spa adds PA-led hormone and weight program

The new clinician is Samantha Youngs, PA-C, a board-certified Physician Associate with experience in family medicine and general surgery. She will lead the wellness program. The release does not say when she started.

What changed

The practice now offers bioidentical hormone replacement therapy, medical weight management with GLP-1 drugs "when appropriate," peptide therapies, nutritional and lifestyle counseling, and body composition checks. The checks set a baseline and track progress. The release says the services cover men and women.

Owner Kristina Thissen, PA-C, says patients pushed the practice toward this work. She says women in perimenopause and menopause have told her their symptoms are often dismissed. Thissen also said more patients of both sexes are dealing with hormone changes and weight problems. Those patients need a full medical workup, not a single product.

Youngs's stated focus includes postpartum wellness, perimenopause, hormone and metabolic health, and longevity. The release says she builds individualized plans that combine medical care, preventive steps and lifestyle changes. She holds a bachelor's degree from North Dakota State University and a master's from St. Ambrose University.

The practice also moved into a larger space at its Maple Grove site. Remedy marked its fifth anniversary in July. The release gives no revenue, patient counts or pricing.

What it means for practices

This is a familiar pattern now. An aesthetic practice with a PA or NP owner adds hormone and metabolic services, and the new revenue sits next to the injectables and lasers that pay the rent today. What stands out here is the order. Remedy hired the clinician first and built the program around her training, which is the reverse of how many owners do it. They bought the chair before they found the player.

The business risk is also clearer than the release lets on. Hormone therapy and GLP-1 prescribing draw scrutiny from state medical boards. They also require lab work and consent records that a laser program does not. A practice that adds a wellness track without a written protocol for who prescribes, what labs run first and how follow-up happens may be taking on risk it has not priced.

What owners can do

If you are considering the same move, start with the clinical scope. Confirm in writing which licensed clinician can order and renew BHRT and GLP-1 prescriptions under your state's rules, and whether a supervising physician must sign off. Set intake and lab protocols before the first patient books. Price the program on the visit and monitoring, not only on the drug. Monitoring is where the staff hours go. Track the cohort separately from aesthetics so you can see whether the wellness patients return, and whether they buy aesthetic services too.

What we don't know yet

The release does not name the state licensing or supervision setup for Youngs, the drug suppliers, the pricing or the patient volume. It also does not say whether the practice uses compounded peptides, which raises its own regulatory questions. Those answers would tell an owner more than the expansion release does.

Business information, not medical or legal advice. Verify regulatory status at FDA.gov.